Rubrik’s modeled fair value has been trimmed slightly, with the price target moving from US$86.71 to US$85.40, a modest 1.5% reduction. Analysts tie this change less to company specific disappointment ...
Monitoring a constant stream of data doesn’t help people make health-related decisions and can lead to confusion and needless ...
Data volumes and real-time dashboards create pressure to act quickly. That speed can be an advantage, but it also amplifies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results